Selegiline Transdermal Patch (Emsam) for Major Depressive Disorder

摘要

At the target dose of 6 mg per 24 hours, tyramine dietary restrictions are not needed.2 Transdermal selegiline is contraindicated in patients taking selective serotonin reuptake inhibitors; dual serotonin and norepinephrine reuptake inhibitors; tricyclic antidepressants; bupropion (Wellbutrin); mirtazapine (Remeron); buspirone (Buspar); and certain analgesics, vasoconstrictors, sympathomimetics, and anticonvulsants.